Grocapix M 5% Solution contains Minoxidil 5% w/v, a potent vasodilator primarily indicated for the treatment of androgenetic alopecia in adult patients. Minoxidil acts by prolonging the anagen phase of the hair growth cycle and increasing blood flow to hair follicles, thereby promoting hair regrowth and preventing further hair loss. This topical solution is applied directly to the scalp, typically twice daily, ensuring localized effect with minimal systemic absorption. Grocapix M 5% Solution is suitable for use in both men and women experiencing pattern hair loss, although efficacy and safety profiles are well established in male patients. Common adverse effects may include scalp irritation, itching, dryness, or erythema at the application site; these are generally mild and transient. Patients should avoid contact with eyes and mucous membranes and discontinue use if severe irritation or hypersensitivity reactions occur. It is contraindicated in individuals with hypersensitivity to Minoxidil or any component of the formulation. Use during pregnancy and lactation should be under medical supervision. Consistent and prolonged use is necessary to maintain therapeutic benefits, with visible results typically observed after 4 months of continuous application. Grocapix M 5% Solution should be stored at room temperature, protected from light and moisture.